Citigroup Downgrades Syneos Health to Neutral From Buy, Adjusts Price Target to $105 From $115
© MT Newswires 2021
| All news about SYNEOS HEALTH, INC. |
|
| 05/10 | Syneos Health Leaders Recognized by HBA | AQ |
| 05/02 | Syneos Health Names Michelle Keefe as Next Chief Executive Officer | AQ |
| 05/02 | Syneos Health Reports First Quarter 2022 Results | AQ |
| 04/29 | SYNEOS HEALTH, INC. : Change in Directors or Principal Officers, Financial Statements and .. | AQ |
| 04/29 | SYNEOS HEALTH : Q1 2022 Financial Results Presentation | PU |
| 04/29 | Syneos Health Promotes Michelle Keefe to CEO, Michael Brooks to COO | MT |
| 04/29 | Syneos Health's Q1 Adjusted Earnings, Revenue Increase; Boosts FY22 EPS Guidance | MT |
| 04/29 | Earnings Flash (SYNH) SYNEOS HEALTH Posts Q1 EPS $1.01, vs. Street Est of $0.96 | MT |
| 04/29 | Earnings Flash (SYNH) SYNEOS HEALTH Posts Q1 Revenue $1.34B, vs. Street Est of $1.325B | MT |
| 04/29 | TRANSCRIPT : Syneos Health, Inc., Q1 2022 Earnings Call, Apr 29, 2022 | CI |
| |
|
| Analyst Recommendations on SYNEOS HEALTH, INC. |
|
| |
|
|
|
| Sales 2022 |
5 670 M
-
-
|
| Net income 2022 |
296 M
-
-
|
| Net Debt 2022 |
2 684 M
-
-
|
| P/E ratio 2022 |
24,6x |
| Yield 2022 |
- |
|
| Capitalization |
7 176 M
7 176 M
-
|
| EV / Sales 2022 |
1,74x |
| EV / Sales 2023 |
1,54x |
| Nbr of Employees |
26 751 |
| Free-Float |
59,7% |
|
| Chart SYNEOS HEALTH, INC. |
|
|
Duration :
Period :
|
 | |
|
Technical analysis trends SYNEOS HEALTH, INC.
| Short Term | Mid-Term | Long Term | | Trends | Neutral | Bearish | Bearish |
Income Statement Evolution
|
| Mean consensus |
BUY |
| Number of Analysts |
11 |
| Last Close Price |
69,96 $ |
| Average target price |
92,60 $ |
| Spread / Average Target |
32,4% |
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
